Overview
Get ready to jumpstart your ODAC experience with one of our favorite traditions! The ODAC Virtual Pre-Conference Symposium returns this November with an interactive, high-energy evening dedicated to the art and science of medical dermatology.
If you enjoy the challenge of working through complex cases, sharpening your diagnostic instincts, and hearing how experts approach real-world clinical dilemmas, this is the session for YOU! From therapeutic curveballs to “what would you do next?” moments, we’ll tackle the kinds of cases that keep dermatologists thinking long after the patient walks out the door.
Join ODAC co-chair Dr. Adam Friedman alongside an outstanding panel of faculty as we break down some of the most challenging, thought provoking, and practice changing cases in dermatology today. Expect lively discussion, practical takeaways you can apply immediately, and plenty of clinical pearls along the way.
So grab your beverage and/or snack of choice, log in from wherever you are, and get ready for an engaging evening of education, debate, and diagnostic detective work.
This year’s symposium will cover:
- Supportive Oncodermatology: Essential insights into managing cutaneous toxicities and improving patient outcomes, led by Dr. Blair Allais.
- Prurigo Nodularis: Expert strategies for breaking the itch-scratch cycle and mastering modern management, directed by Dr. Maxwell Sauder.
- Complex Breast Dermatoses: Navigating the diagnostic and therapeutic hurdles of these complex inflammatory conditions, with Dr. Emily Nadelmann.
- GLP-1 Agonists in Dermatology: Exploring the revolutionary role of GLP-1s in treating Hidradenitis Suppurativa and Psoriasis, presented by Dr. George Han.
Each session features a lively panel discussion and a real-time audience Q&A, delivering high-impact takeaways you can put into practice the very next morning.
Whether you’re looking to supercharge your clinical toolkit or stay at the absolute forefront of medical dermatology, this symposium will challenge your perspective and elevate your patient care. Register today!
Chair
Adam Friedman, MD, FAAD
Professor and Chair Director Residency Program Director Translational Research Director Supportive Oncodermatology Director Hidradenitis Suppurativa Clinic Department of Dermatology The George Washington University School of Medicine and Health Sciences Washington, DC
Faculty
Blair Allais, MD, FAAD
Dermato-Oncologist Assistant Professor Department of Medicine University of Virginia Inova Schar Cancer Institute Melanoma and Skin Oncology Center Fairfax, Virginia
Emily R. Nadelmann, MD, FAAD
Clinical Assistant Professor Department of Dermatology George Washington School of Medicine and Health Sciences Clinical Assistant Professor Department of Dermatology University of Maryland School of Medicine Washington, DC
George Han, MD, PhD, FAAD
Associate Professor Department of Dermatology Zucker School of Medicine at Hofstra/Northwell Hofstra University Hempstead, New York
Maxwell B. Sauder, MD, FRCPC, FAAD, FCDA
Assistant Professor Division of Dermatology Department of Medicine University of Toronto Toronto, Ontario, Canada Associate Investigator Probity Medical Research Waterloo, Ontario, Canada
Agenda
Please note all sessions listed in Eastern Time. Agenda subject to change.
Thursday, November 19
6:00 pm — 7:00 pm
Challenging Medical Dermatology Cases: A Case-Based Conversation With the Experts, Part 1
Conference Welcome & Session Introduction
Supportive Oncodermatology: Essential Insights into Managing Cutaneous Toxicities and Improving Patient Outcomes
Prurigo Nodularis: Expert Strategies for Breaking the Itch-Scratch Cycle and Mastering Modern Management
Panel Discussion and Audience Q&A
Blair Allais, MD, FAAD
Maxwell B. Sauder, MD, FRCPC, FAAD, FCDA
Thursday, November 19
7:00 pm — 8:00 pm
Non-CME/CE Bonus Presentation
Thursday, November 19
8:00 pm — 9:00 pm
Challenging Medical Dermatology Cases: A Case-Based Conversation With the Experts, Part 2
Session Introduction
Complex Breast Dermatoses: Navigating Diagnostic and Therapeutic Hurdles
GLP-1 Agonists in Dermatology: Exploring the Revolutionary Role of GLP-1s in Treating Hidradenitis Suppurativa and Psoriasis
Panel Discussion and Audience Q&A
George Han, MD, PhD, FAAD
Emily R. Nadelmann, MD, FAAD
Accreditation
TARGET AUDIENCE
The intended audience for this live activity includes dermatologists, dermatology residents, fellows and young practitioners, dermatology nurse practitioners and physician assistants, and other healthcare providers with an interest in treating patients with cutaneous diseases and disorders in persons of all ages and skin types.
LEARNING OBJECTIVES
After completing this activity, the participant should be better able to: [LIST] [ITEM]Identify the most common dermatologic adverse events associated with systemic cancer therapies and describe their underlying mechanisms and clinical presentations. [ITEM]Develop individualized management plans for patients with prurigo nodularis by integrating current treatment guidelines, patient-reported outcomes, and novel therapeutic options aimed at disrupting the itch-scratch cycle. [ITEM]Differentiate among common and uncommon breast dermatoses, recognize clinical features that warrant further investigation for underlying malignancy or systemic disease, and implement evidence-based diagnostic and therapeutic strategies to optimize patient outcomes. [ITEM]Evaluate the emerging role of GLP-1 receptor agonists in dermatology, including their mechanisms of action, clinical evidence, and potential therapeutic benefits in the management of hidradenitis suppurativa and psoriasis, and apply current evidence to identify appropriate patients who may benefit from these novel treatment approaches. [ITEM]Apply confidence in their ability to communicate effectively and work as part of the interprofessional team to optimize patient care.
ACCREDITATION STATEMENTS
[JALOGOGAME] In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and National Medical Education Corporation. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
[bold]Credit Designation [/bold] [bold]Physician Continuing Medical Education [/bold] The Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 [italic]AMA PRA Category 1 Credit(s)™[/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]Continuing Nursing Education [/bold] The maximum number of hours awarded for this Continuing Nursing Education activity is 2.0 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on your certificate. [bold]Continuing Physician Assistant Education [/bold] [AAPA] Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. [bold]Interprofessional Continuing Education [/bold] [ICPE] This activity was planned by and for the healthcare team, and learners will receive 2.0 Interprofessional Continuing Education (IPCE) credit for learning and change. [bold]Disclosure of Conflicts of Interest [/bold] Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. The existence or absence of COI for everyone in a position to control educational content will be disclosed to participants prior to the start of each activity.